USPTO Patent Application: Modified Release Minoxidil for Hair Loss

ChangeBridge: Patent Apps - Pharma (A61K)

Published December 1st, 2025

Detected March 26th, 2026

Summary

The USPTO has published a patent application (US20260083738A1) detailing modified release minoxidil oral formulations for treating hair loss. The application, filed by Reid Waldman, describes compositions including minoxidil alone or with other active agents, and methods of treatment. This represents a new patent filing for a potential pharmaceutical product.

View original document View source feed page

What changed

This document is a USPTO patent application (US20260083738A1) for modified release oral formulations of minoxidil, intended for treating hair loss. The application, filed on December 1, 2025, by inventor Reid Waldman, covers pharmaceutical compositions containing minoxidil or its salts, potentially combined with other active agents, as well as methods of use and kits. This filing indicates a new development in the intellectual property landscape for hair loss treatments.

As this is a patent application, it does not impose immediate regulatory obligations on pharmaceutical companies or healthcare providers. However, it signals potential future market exclusivity for the applicant if the patent is granted. Companies involved in hair loss treatments or minoxidil formulations should monitor this application's progress and consider its implications for their own product development and intellectual property strategies.

Source document (simplified)

← USPTO Patent Applications

COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL

Application US20260083738A1 Kind: A1 Mar 26, 2026

Inventors

Reid WALDMAN

Abstract

The compositions and methods provided herein include a pharmaceutical formulation for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical formulations for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof and one or more additional active agents. Also provided herein are methods of treating hair loss by administering to a subject in need thereof a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Further provided herein is a kit including a slow modified release vehicle comprising oral minoxidil or a pharmaceutically acceptable salt thereof.